MavriX Bio
PrivateLast Round
Corporate Funding
Feb 14, 2025
Company Overview
MavriX Bio operates in Healthcare & Life Sciences and is based in San Mateo, California. Its latest recorded funding round was a Corporate Funding round in February 2025.
MavriX Bio is a biotechnology company developing gene replacement therapies for the treatment of Angelman syndrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MavriX Bio Comparables
Compare MavriX Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Encoded Therapeutics | 88% | |
| Oak Hill Bio | 83% | |
| Couragene | 78% |
For institutional investors. Book with your work email.
MavriX Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Feb 14, 2025 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 14, 2025
Led by Foundation for Angelman Syndrome Therapeutics and AS²Bio Inc.
For institutional investors. Book with your work email.
MavriX Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MavriX Bio's valuation, stock price, and market status.
Is MavriX Bio a public or private company?
MavriX Bio is a private company.
What is the current stock price of MavriX Bio?
MavriX Bio is a private company, so its shares have no public market price. Caplight tracks MavriX Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MavriX Bio worth (valuation)?
Valuation information for MavriX Bio is not publicly available.
Can I buy MavriX Bio stock?
MavriX Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MavriX Bio's last funding round?
MavriX Bio's most recent funding round was Corporate Funding on February 14, 2025.
Who are the main investors in MavriX Bio?
Investor information for MavriX Bio is not publicly disclosed.
Will MavriX Bio IPO soon?
No public IPO plans have been announced for MavriX Bio.
How can I track MavriX Bio secondary market activity?
Caplight tracks bids, offers, and trades in MavriX Bio's shares on secondary markets.